BeStock  
Stocks › ALGN

Align Technology ALGN

US equityMarket cap rank #1341
$155.17 −$4.51 (-2.82%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $155.17 0.00%
Open$159.71
Prev close$159.68
Day range$154.52 – $162.18
Volume1.31M
Market cap$10.94B
P/E (TTM)22.6
Dividend yield–
Founded1997
CEOMr. Joseph M. Hogan
Employees20,290
HeadquartersTempe, United States of America
Websitewww.aligntech.com

Revenue per employee

$131.8K$155.8K$179.8K$203.8KDec '18Dec '21Dec '25

20,290 employees as of 2025/FY (-3.1% YoY). Revenue per employee is total revenue divided by headcount — a rough productivity gauge, not a per-worker pay figure.

Management team

Joseph M. Hogan President, Chief Executive Officer and Director
Age 68 · Total comp. $19,193,988.00 · As of 27 Oct 2026
Background

Joseph M. Hogan Experience: 2015 - Present President and CEO, Align Technology Inc. (dental technology company) Prior CEO, ABB (technology company) Various Positions including CEO of GE Healthcare, General Electric (a medical technology company) Other Board Positions Supervisory Board of avateramedical N.V. (2019-2021) Notable Experience and Key Board Contributions At Align, Mr. Hogan has overseen significant financial and operating performance. Mr. Hogan is a proven leader serving as an integral connection between our board of directors and management. He brings to Align significant leadership experience from large public companies, with strategic business, market development and sales acumen, and expertise in strategic and operational aspects of complex, international organizations. During his five years at ABB, Mr. Hogan oversaw a 25% increase in revenues. As CEO of GE Healthcare, Mr. Hogan drove significant geographic and market portfolio expansion and more than doubled revenues from $7 billion to $16 billion. Education B.S. in Business and Economics from Geneva College M.B.A. from Robert Morris University. Joseph M. Hogan will continue to serve as the Company's President and CEO through December 31, 2026

John F Morici Principal Accounting Officer, Chief Financial Officer and Executive Vice President, Global Finance
Age 59 · Total comp. $5,700,334.00 · As of 26 Feb 2026
Background

Mr. John F Morici, Principal Accounting Officer, Chief Financial Officer and Executive Vice President, Global Finance - 2022-Present, Chief Financial Officer and Senior Vice President, Global Finance of Align - 2018-2022, Chief Financial Officer of Align - 2016-2018, EVP and Managing Director of NBC Universal North America Home Entertainment - 2014-2016, CFO/Chief Operating Officer of NBC Universal North America Home Entertainment - 2011-2014, Senior Vice President and Chief Financial Officer of NBC Universal North America Home Entertainment - 2007-2011.

Stuart A. Hockridge Executive Vice President, Global Human Resources
Age 54 · Total comp. $2,774,309.00 · As of 26 Feb 2026
Background

Mr. Stuart A. Hockridge, Executive Vice President, Global Human Resources - 2022-Present, Senior Vice Present, Global Human Resources of Align - 2018-2022, Vice President, Global Human Resources of Align - 2016-2018, Vice President of Talent of Visa - 2013-2016.

Anne M. Myong Independent Director
Age 58 · Total comp. $390,483.00 · As of 6 Apr 2026
Background

Anne M. Myong Experience: 2021 - 2023 President, Amyris, Inc. (biotechnology company) 2020 - 2021 Chief Executive Officer and Chief Financial Officer, Aura Financial (financial services company) 2014 - 2017 Senior Vice President and Chief Financial Officer, Walmart Global eCommerce (eCommerce segment of retail corporation) 2011 - 2014 Senior Vice President, Chief Financial and Administrative Officer, Walmart China Retail (retail corporation) Prior Vice President and Chief Financial Officer, Agilent Technologies China (life science software and supplies company) Other Board Positions Goodwill Industries International, Inc. (2016-2022) Wal-Mart de Mexico, S.A.B. de C.V. (2016-2017) Notable Experience and Key Board Contributions Ms. Myong brings extensive experience in global operations, finance and accounting with a unique knowledge of international markets, a deep understanding of financial reporting and organizational risks, controls and monitoring, and expertise in consumer products, omnichannel retailing, digital marketing, and scaling industry-transforming innovations. As Senior Vice President and Chief Financial Officer of Walmart Global eCommerce, Ms. Myong accelerated the growth, profitability, and digital transformation of Walmart's retail and e-commerce operations in the United States, China, and Brazil. Education B.B.A. in Computer Information Systems from James Madison University M.B.A. from Harvard Business School.

Kevin J. Dallas Independent Director
Age 62 · Total comp. $378,483.00 · As of 6 Apr 2026
Background

Kevin J. Dallas Experience: 2023 - Present CEO, EnterpriseDB Corporation (software company) 2020 - 2022 CEO, Wind River Systems, Inc. (software company) 1996 - 2020 Corporate Vice President, Cloud & AI Business Development, Microsoft (software company) Prior Various Positions, NVIDIA Corporation and National Semiconductor, now Texas Instruments Inc. (technology company) Other Board Positions EnterpriseDB (2023-present) Notable Experience and Key Board Contributions Mr. Dallas brings more than 25 years of experience driving digital innovation and growth at technology companies and expertise in the digital transformation of customers and partners as well as AI. At Microsoft, Mr. Dallas enabled the digital transformation of customers and partners across a range of industries including: connected/autonomous vehicles, industrial IoT, discrete manufacturing, retail, financial services, media and entertainment, and healthcare. Mr. Dallas has deep expertise in cybersecurity, artificial intelligence, machine learning and information technology. Education B.S.c. in Electrical and Electronic Engineering from Staffordshire University.

Joseph S. Lacob Independent Director
Age 70 · Total comp. $369,983.00 · As of 6 Apr 2026
Background

Joseph Lacob Experience: 2010 - Present Governor, Co-Executive Chairman and CEO, Golden State Warriors (basketball team) and Golden State WNBA (basketball team) 1987 - 2010 Partner, Kleiner Perkins Caufield & Byers (venture capital firm) Prior Various Positions, Cetus Corporation, now Chiron Corporation (biotechnology company) Various Positions, FHP International (health maintenance organization) Various Positions, Booz, Allen & Hamilton (consulting firm) Other Board Positions Golden State Warriors (2010-present) NeuroPace, Inc. (1997-present) Orexigen Therapeutics, Inc. (2004-2012) Notable Experience and Key Board Contributions Mr. Lacob brings expertise in evaluating and developing strategic opportunities, specifically in the technology, healthcare and life sciences industries. Mr. Lacob also has significant consumer marketing, financial, strategic investment and mergers and acquisition experience. Mr. Lacob was closely involved with KPCB's investments in more than 50 life science companies, including the startup or incubation of a dozen ventures, and with KPCB's medical technology practice, which includes more than 30 therapeutic and diagnostic medical device companies. Education B.S. in Biological Sciences from the University of California at Irvine Masters in Public Health from the University of California at Los Angeles M.B.A. from Stanford University.

Kevin T. Conroy Chairman of the Board
Age 60 · Total comp. $363,483.00 · As of 21 Jun 2026
Background

Experience: 2009 - 2026 CEO and Chairman of the Board (2014), Exact Sciences Corp. (molecular diagnostics company) 2005 - 2008 President and CEO, Third Wave Technologies, Inc. (molecular diagnostics company) 2004 - 2005 General Counsel, Third Wave Technologies, Inc. (molecular diagnostics company) Prior Various Leadership Positions at GE Healthcare (medical technology company) Other Board Positions Exact Sciences Corp. (2014-2026) Fuze Health (2025-present) Adaptive Biotechnologies Corporation (2019-2023) Epizyme, Inc. (2017-2022) CM Life Sciences II Inc. (2021) SomaLogic, Inc. (2021) Arya Sciences Acquisition Corp. (2018-2020) Notable Experience and Key Board Contributions Mr. Conroy has extensive experience creating stockholder value as a business, legal, corporate strategy, and executive leader and has significant experience in the healthcare and the molecular diagnostics industries. At Exact Sciences, Mr. Conroy helped to develop Cologuard and the company has grown to $2.76B in revenue while serving 4.5 million patients. At Third Wave, Mr. Conroy developed and brought a novel cervical cancer screening test, Cervista, to patients. Education B.S. in Electrical Engineering from Michigan State University J.D. from the University of Michigan Law School. on June 17, 2026, the Board appointed Kevin Conroy, an independent director, to serve as Chairman of the Board, effective July 1, 2026.

Mojdeh Poul Independent Director
Age 63 · Total comp. $363,483.00 · As of 6 Apr 2026
Background

Ms. Mojdeh Poul, Experience: 2025 - Present President and Chief Executive Officer, Integra LifeSciences Holdings Corporation (global medical technology company) 2019 - 2022 Executive Vice President and Group President, 3M Healthcare Business Group (global healthcare products company) 2011 - 2018 Various Global Executive Leadership Positions, 3M Healthcare Business Group (global healthcare solutions company) and 3M (diversified global company) 2005 - 2011 Various Global Business Leadership Positions, Medtronic (global medical technology company) Prior Various Marketing Leadership Positions, ev3 (medical device company) Various Global Marketing Leadership Positions, Boston Scientific (global medical technology company) Various Management Positions, Teleflex Medical (global medical device company) Various Engineering Positions, GE Plastics (global engineering plastics company) Other Board Positions Integra LifeSciences Holdings Corporation (2025-Present) CeramTec Advisory Committee (2022-Present) iRhythm Technologies (2023-2025) Stanley Black and Decker (2021-2025) Notable Experience and Key Board Contributions Ms. Poul has 30 years of experience in various segments of the healthcare industry. She has a proven track record of delivering business growth and performance though portfolio transformation, value-creating innovation, and impactful capital allocation. Ms. Poul has deep expertise in corporate strategy, mergers and acquisitions, global profit and loss and operations management, and commercial excellence. Education M.B.A. from the University of North Carolina, Chapel Hill Masters in Mechanical Engineering from the University of Louisville B.S. in Mechanical Engineering from the University of Louisville.

Susan E. Siegel Independent Director
Age 65 · Total comp. $359,983.00 · As of 6 Apr 2026
Background

Susan E. Siegel Experience: Ms. Siegel served as Chief Innovation Officer at General Electric from 2017 to 2019, and previously as CEO of GE Ventures and Licensing from 2012 to 2017; prior to that, she was a General Partner at Mohr Davidow Ventures focusing on investments in personalized medicine, life sciences, and digital health, and earlier served as Director and President of Affymetrix. 2017 - 2019 Chief Innovation Officer, GE (conglomerate company) 2012 - 2017 CEO, GE Ventures and Licensing (conglomerate company) Prior General Partner, Mohr Davidow Ventures (multidisciplinary investment firm; Ms. Siegel focused investments in personalized medicine, life sciences and digital health) Director and President, Affymetrix (genomics company) Other Board Positions Illumina, Inc. (2019-present) The Engine (2016-2020), Chair (2020-present) KFF (formerly Kaiser Family Foundation) (2019-present) Nevro Corporation (2020-2025) National Venture Capital Association (2012-2016) Pacific Biosciences, Inc. (2006-2013) Tech Interactive (2003-2007) Affymetrix (2000-2006) Notable Experience and Key Board Contributions Ms. Siegel brings extensive experience in identifying, funding, pioneering, and implementing industry-shifting innovations in the life sciences, biomedical research, and healthcare industries. Ms. Siegel led Affymetrix, one of the fastest growing genomics companies of its time. She led it from a pre-revenue startup to a multi-billion dollar publicly listed company that helped shape the emerging genomics industry, including addressing the bioethical issues of its day. Ms. Siegel has been recognized in Fortune's 34 Leaders Who Are Changing Health Care, as one of The 100 Most Influential Women in Silicon Valley, Fierce Biotech's Top 10 Women in Medical Devices, and was awarded the Lifetime Achievement Award by Global Corporate Venture in 2020. She is an Aspen Institute Henry Crown Fellow and is a featured Multiplier in the bestselling book: Multipliers: How the Best Leaders Make Everyone Smarter. Education B.S. in Biology from the University of Puerto Rico M.S. in Biochemistry and Molecular Biology from Boston University Medical School.

Britt J. Vitalone Independent Director
Age 56 · Total comp. $312,096.00 · As of 6 Apr 2026
Background

The Board of Directors of Align Technology, Inc. appointed Britt Vitalone to the Board, effective July 2, 2025. Mr. Vitalone currently serves as Executive Vice President and Chief Financial Officer for McKesson Corporation and is a member of the executive operating team. He is responsible for ensuring that the company's strategy creates and aligns to shareholder value; communicating the company's strategies and performance to investors; and implementing a capital structure, financial processes and controls to support the company's growth and return on investment goals. As CFO, Mr. Vitalone oversees the accounting, financial planning and analysis, treasury, real estate, investor relations, internal audit, merger & acquisition and tax functions at McKesson. In addition to leading McKesson's Enterprise Finance organization, he also oversees the company's global procurement and sourcing, corporate security, and McKesson Technology (MT) organizations. Mr. Vitalone joined McKesson in 2006 and has served as a financial executive leader in several major businesses within the company, including senior vice president & CFO of McKesson's U.S. Pharmaceutical and Specialty Health unit. Additionally, he was senior vice president of Corporate Finance and Merger & Acquisition Finance, and senior vice president & CFO of McKesson's Medical-Surgical unit. Outside of McKesson, Mr. Vitalone is a member of the CNBC Global CFO Council. Mr. Vitalone holds a Bachelor of Science in Accounting from St. John Fisher University.

Jennifer L. Davis Director
Age 55 · As of 27 Oct 2026
Background

On October 26, 2026, the Board of Directors of Align Technology, Inc. appointed Jennifer L. Davis as Chief Executive Officer-elect and director of the Company, effective November 2, 2026, and as President and Chief Executive Officer of the Company, effective December 31, 2026.Ms. Davis, 55, brings 33 years of experience that included leading innovation, digital transformation, brand building and complex organizations at scale. Prior to joining the Company, she served as Chief Executive Officer, Health Care of The Procter & Gamble Company (P&G) from 2022 through June 2026. From 2018 to 2022, she held senior leadership roles in P&G's global Feminine Care business. During her more than 30-year career at P&G, she also held a series of commercial and general management roles of increasing responsibility. Ms. Davis has served as a member of the board of directors of AbbVie Inc. since 2023.

Quentin S. Blackford Director
Age 48 · As of 30 Aug 2026
Background

Quentin Blackford was appointed to the board as a director with effect from 31st August 2026. Mr. Blackford currently serves as President and Chief Executive Officer of iRhythm Technologies, a leading digital healthcare company focused on advancing cardiac care. He has served in this role since 2021. Before joining iRhythm, Mr. Blackford served as Chief Operating Officer of Dexcom, where he helped lead the company's global operations, corporate strategy, and international growth initiatives. Previously, he held senior finance and leadership positions at NuVasive and Zimmer Holdings. Mr. Blackford currently serves on the board of Alphatec Holdings and is a Certified Public Accountant (inactive). He earned dual Bachelor of Science degrees in Accounting and Business Administration from Grace College.

From SEC filings, via Futu. Compensation is total reported pay for the most recent fiscal year on file, not base salary alone.

Discussion

No comments yet — be the first to weigh in on ALGN.

Sign in to join the discussion.

Scroll to Top